Cardiovascular Morbidity and Mortality in Fabry Disease
This study shows that the prevention and treatment of cardiovascular disease remain an unmet need for patients with Fabry disease.
Authors
- Vanda Parisi (ORCID: https://orcid.org/0000-0002-6895-0040)
- Emanuele Monda (ORCID: https://orcid.org/0000-0001-9304-988X)
- Maria Alessandra Schiavo
- Francesca Graziani (ORCID: https://orcid.org/0000-0002-4520-5689)
- Maurizio Pieroni (ORCID: https://orcid.org/0000-0002-6830-4292)
- Maria Chiara Meucci (ORCID: https://orcid.org/0000-0001-5474-0555)
- Athanasios Bakalakos (ORCID: https://orcid.org/0009-0006-6356-2205)
- Uma Ramaswami
- E. Biagini
- Derralynn Hughes
- R Lillo
- L Spinelli
- G Limongelli
- Robin Lachmann
- G I Guido Iaccarino
- Elaine Murphy
- Antonio Pisani
- Marta Rubino
- Francesco Cappelli
- Perry Mark Elliott
Institutions
- Royal Free London NHS Foundation Trust (GB)
- Cardiovascular Institute of the South (US)
- Agostino Gemelli University Polyclinic (IT)
- Federico II University Hospital (IT)
- Azienda USL di Bologna (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Ospedale Monaldi (IT)
- ERN GUARD-Heart (NL)
- National Hospital for Neurology and Neurosurgery (GB)
- University of Florence (IT)
- University College London (GB)
Publication Details
- Journal
- Circulation Genomic and Precision Medicine
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1161/circgen.125.005361
- Citations
- 2
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 65.68